Works matching IS 03065251 AND DT 2025 AND VI 91 AND IP 4

Results: 38

Correction to "EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cells".

Published in:: British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1285, doi. 10.1002/bcp.70033
Publication type:: Article

Alternative splicing with CYP3A4*22: Implications for the steroid‐tacrolimus drug interaction.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1283, doi. 10.1002/bcp.70029

By:

Stojanova, Jana;
Helsby, Nuala Ann;
Wright, Daniel F. B.;
Murnion, Bridin;
Day, Richard O.

Publication type:

Article

Academic development of advanced therapies—How to foster their future in the clinic.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1080, doi. 10.1002/bcp.70024

By:

Hidalgo‐Simon, Ana;
Pothet, Caroline;
Cooke, Emer;
Thirstrup, Steffen

Publication type:

Article

Navigating challenges and opportunities in orphan medicines: A spotlight commentary on rare diseases.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1084, doi. 10.1002/bcp.70013

By:

Belančić, Andrej;
Gkrinia, Elvira Meni Maria;
Likić, Robert;
Vitezić, Dinko

Publication type:

Article

Drug reaction with eosinophilia and systemic symptoms induced by paclitaxel, a rare combination.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1281, doi. 10.1002/bcp.70012

By:

Lagassy, Mathieu;
Barthelemy, Mathilde;
Kieffer, Camille;
Boulay, Charlene;
Bourneau‐Martin, Delphine;
Veyrac, Gwenaëlle;
Lafon, Audrey;
Bauvin, Olivia;
Augusto‐Pelegrin, Laetitia;
Lefebvre, Alexis;
Tetart, Florence

Publication type:

Article

Spotlight commentary: Innovations in clinical trials.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1088, doi. 10.1002/bcp.70010

By:

Hudej, Nataša;
Aumiler, Matea Radačić

Publication type:

Article

Prescriptions of CYP3A4‐ and P‐gp inducers for patients on direct oral anticoagulants: Bridging the gap between epidemiology and patient management for optimal thromboembolic event prevention.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1114, doi. 10.1002/bcp.70007

By:

Wuyts, Stephanie C. M.;
Moor, Joris De;
Jochmans, Kristin;
Cortoos, Pieter‐Jan;
Vandervorst, Fenne;
Steurbaut, Stephane;
Dupont, Alain G.;
Cornu, Pieter

Publication type:

Article

Adherence and persistence with direct oral anticoagulants by dose regimen: A systematic review.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1096, doi. 10.1002/bcp.70003

By:

Quirós López, Raúl;
Formiga Pérez, Francesc;
Beyer‐Westendorf, Jan

Publication type:

Article

Optimizing real‐world evidence studies for regulatory decision‐making and impact assessment in pharmacovigilance.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1092, doi. 10.1111/bcp.16393

By:

Ioakeim‐Skoufa, Ignatios;
Atkins, Kerry;
Hernández‐Rodríguez, Miguel Ángel

Publication type:

Article

Co‐prescription of low‐dose methotrexate and trimethoprim‐sulfamethoxazole and the 30‐day risk of death among older adults: A cohort study.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1263, doi. 10.1111/bcp.16365

By:

Sadeghi, Hasti;
Ahmadi, Fatemeh;
McArthur, Eric;
Sontrop, Jessica M.;
Abdullah, Sheikh S.;
Urquhart, Brad L.;
Kim, Richard B.;
Muanda, Flory T.

Publication type:

Article

Medication review interventions for adults living with advanced chronic kidney disease: A scoping review.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1132, doi. 10.1111/bcp.16363

By:

Pogson, Cathy Margaret;
Austin, Rosalynn;
Patel, Jignesh Prakash;
Wheeler, David Collins

Publication type:

Article

Systematic review and meta‐analysis of vancomycin therapeutic level for treatment of vancomycin‐sensitive enterococcal infections.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1250, doi. 10.1111/bcp.16362

By:

Katip, Wasan;
Lee, Shaun Wen Huey;
Kasatpibal, Nongyao;
Rayanakorn, Ajaree

Publication type:

Article

Impact of ABCB1 single‐nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin‐bound paclitaxel in patients with gastric cancer.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1216, doi. 10.1111/bcp.16359

By:

Maeda, Akimitsu;
Matsuo, Keitaro;
Ando, Hitoshi;
Morishige, Jun‐ichi;
Muro, Kei;
Uchida, Kosaku;
Tajika, Masahiro

Publication type:

Article

Influence of gut bile acid composition on the glucose‐lowering effect and safety of metformin.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1208, doi. 10.1111/bcp.16358

By:

Yoon, Deok Yong;
Kim, Jungeun;
Cho, Joo‐Youn;
Chung, Jae‐Yong

Publication type:

Article

Core medication use in general practice prescriptions: A pilot study evaluating the Drug Utilization 90% Index in Irish general practice.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1241, doi. 10.1111/bcp.16356

By:

McCarthy, Caroline;
Moynagh, Patrick;
Fahey, Tom;
Boland, Fiona;
Moriarty, Frank

Publication type:

Article

The safety profile of usage of glucagon‐like peptide‐1 receptor agonists in pregnancy: A pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1272, doi. 10.1111/bcp.16354

By:

Zhou, Jianxing;
Wei, Zipeng;
Lai, Weipeng;
Liu, Maobai;
Wu, Xuemei

Publication type:

Article

PBPK modelling for the evaluation of drug–drug interaction between meropenem and valproic acid.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1198, doi. 10.1111/bcp.16350

By:

Liu, Hongrui;
Yu, Yiqun;
Qin, Yulin;
Han, Bing

Publication type:

Article

A simulation study to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonates.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1223, doi. 10.1111/bcp.16345

By:

El Hassani, Mehdi;
Blouin, Mathieu;
Marsot, Amélie

Publication type:

Article

The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1191, doi. 10.1111/bcp.16344

By:

Yeung, Sam Au;
Stein, Daniel S.;
Marbury, Thomas C.;
Usansky, Helen

Publication type:

Article

Adaptive dosing of high‐dose busulfan in real‐world adult patients undergoing haematopoietic cell transplant conditioning.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1171, doi. 10.1111/bcp.16343

By:

Protzenko, Dorian;
Bouchacourt, Benjamin;
Carriat, Laure;
Maroselli, Paul;
Boéri, Clara;
Devillier, Raynier;
Ciccolini, Joseph

Publication type:

Article

Personalized parathyroid hormone therapy for hypoparathyroidism: Insights from pharmacokinetic‐pharmacodynamic modelling.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1233, doi. 10.1111/bcp.16342

By:

Visscher, Maira;
Schuls‐Fouchier, Manon;
Berends, Annika M. A.;
Muller Kobold, Anneke C.;
Punt, Nieko C.;
Touw, Daan J.

Publication type:

Article

What can pharmacokinetic modelling do for you? Rational design and interpretation of clinical studies.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 929, doi. 10.1111/bcp.16341

By:

Ojara, Francis Williams;
Kawuma, Aida N.;
Waitt, Catriona

Publication type:

Article

Determination of the optimal obesity‐adjusted dosing weight for enoxaparin.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1182, doi. 10.1111/bcp.16338

By:

Roberts, Gregory W.;
De Menezes Caceres, Viviane;
Damiani, Anthony;
Scarfo, Nicholas;
Williams, Desmond B.;
Russell, Patrick T.

Publication type:

Article

Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practice.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1064, doi. 10.1111/bcp.16335

By:

Berezowska, Monika;
Hayden, Isaac S.;
Brandon, Andrew M.;
Zats, Arsenii;
Patel, Mehzabin;
Barnett, Shelby;
Ogungbenro, Kayode;
Veal, Gareth J.;
Taylor, Alaric;
Suthar, Jugal

Publication type:

Article

Improving cefazolin exposure in critically ill children using a population pharmacokinetic model.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 981, doi. 10.1111/bcp.16224

By:

Rivaud, Clémence;
Oualha, Mehdi;
Salvador, Elodie;
Bille, Emmanuelle;
Callot, Delphine;
Béranger, Agathe;
Bournaud, Leo Froelicher;
Rouillon, Steeve;
Toubiana, Julie;
Benaboud, Sihem;
Renolleau, Sylvain;
Treluyer, Jean Marc;
Hirt, Déborah;
de Cacqueray, Noémie

Publication type:

Article

Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 968, doi. 10.1111/bcp.16132

By:

Banda, Clifford G.;
Tarning, Joel;
Barnes, Karen I.

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 927, doi. 10.1111/bcp.16103
Publication type:: Article

Physiologically‐based pharmacokinetic modelling guided dose evaluations of nirmatrelvir/ritonavir in renal impairment for the management of COVID‐19.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1041, doi. 10.1111/bcp.16074

By:

Ng, Tat Ming;
Wang, Ziteng;
Chan, Eric Chun Yong

Publication type:

Article

Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1031, doi. 10.1111/bcp.16061

By:

Chao, Chih‐Jia;
Gardner, Iain;
Lin, Chun‐Jung;
Yeh, Kun‐Huei;
Lu, Wan‐Chen;
Abduljalil, Khaled;
Ho, Yunn‐Fang

Publication type:

Article

Model‐based precision dosing and remedial dosing recommendations for delayed or missed doses of isoniazid in Chinese patients with tuberculosis.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 947, doi. 10.1111/bcp.16050

By:

Li, Jin‐Meng;
Zhang, Ruo‐Ying;
Yang, Gao‐Yi;
Cai, Qing‐Shan;
Lang, Ya‐Zhen;
Zhong, Fang‐Ming;
Huang, Jin‐Peng;
Chen, Yuan‐Yuan;
Qin, Yao;
Fang, Li‐Kui;
Ye, Bo;
Lin, Li‐Hua;
Lin, Hui‐Hong;
Cai, Xin‐Jun;
Xu, Kan

Publication type:

Article

A 10‐year retrospective study of antibacterial‐induced thrombocytopenia in a women and children hospital using China Hospital Pharmacovigilance System and Visual Basic for Applications.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1157, doi. 10.1111/bcp.16041

By:

Yang, Jianhui;
Cai, Can;
Pan, Xiuming;
Chen, Weida;
Zhuang, Wei;
Lin, Wanlong;
Chen, Yao

Publication type:

Article

Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 989, doi. 10.1111/bcp.16006

By:

Atoyebi, Shakir;
Bunglawala, Fazila;
Cottura, Nicolas;
Grañana‐Castillo, Sandra;
Montanha, Maiara Camotti;
Olagunju, Adeniyi;
Siccardi, Marco;
Waitt, Catriona

Publication type:

Article

Exploring the impact of ethnicity on drug pharmacokinetics using PBPK models: A case study with lansoprazole in Japanese subjects.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1016, doi. 10.1111/bcp.15982

By:

Ezuruike, Udoamaka;
Curry, Liam;
Hatley, Oliver;
Gardner, Iain

Publication type:

Article

The new big is small: Leveraging knowledge from small trials for rare disease drug development: Blarcamesine for Rett syndrome.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1049, doi. 10.1111/bcp.15843

By:

Ette, Ene I.;
Fadiran, Emmanuel O.;
Missling, Christopher;
Hammond, Edward

Publication type:

Article

Quantification of sertraline maternal/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 1003, doi. 10.1111/bcp.15826

By:

Lartey, David;
Jateng, Danielle;
Li, Miao;
Nguyen, Christine;
Crentsil, Victor;
Beitz, Julie;
George, Blessy

Publication type:

Article

The trajectory of pharmacometrics to support drug licensing and labelling.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 932, doi. 10.1111/bcp.15728

By:

Dunn, Allison;
Gobburu, Jogarao V. S.

Publication type:

Article

Single dose tocilizumab for COVID‐19 associated cytokine storm syndrome: Less is more.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 938, doi. 10.1111/bcp.15690

By:

Boone, Niels W.;
Moes, Dirk Jan A. R.;
Ramiro, Sofia;
Mostard, Remy L. M.;
Magro‐Checa, Cesar;
van Dongen, Christel M. P.;
Gronenschild, Michiel;
van Haren, Eric;
Buijs, Jacqueline;
de Vries, Annick;
Peeters, Ralph;
Landewé, Robert B. M.;
Wong, Dennis R.

Publication type:

Article

Relative bioavailability of delamanid 50 mg tablets dispersed in water in healthy adult volunteers.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 957, doi. 10.1111/bcp.15672

By:

Zou, Yuanxi;
de Jager, Veronique;
Hesseling, Anneke C.;
Diacon, Andreas H.;
Wiesner, Lubbe;
Mostert, Joni;
Svensson, Elin M.;
Garcia‐Prats, Anthony

Publication type:

Article